impactbiomedinc.com - IBO EV/Sales Multiple

The price-to-sales dynamics of Impact BioMedical Inc (IBO) demonstrate current market expectations, where 1413500.00 reflects the latest metric value. The financial stability of Impact BioMedical Inc (IBO) has been undermined by fragmented assets and a high cash burn rate. Capitalization growth is based on the successful licensing of medical patents and the implementation of R&D projects. The holding company is currently focusing on organic license control and targeted partnerships in incubation mode.
Impact BioMedical - analytical breakdowns and key metrics (IBO)

This indicator determines the market value of the business adjusted for net debt, comparing it to annual sales volume to identify the degree of asset undervaluation. The Enterprise Value to Revenue trend reflects the capitalization of Impact BioMedical Inc (IBO) in the context of scaling intellectual property, which is critical for assessing the prospects of medical technology licensing and strategic partnerships planned for 2026.